Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atossa Therapeutics Inc
(NQ:
ATOS
)
1.405
+0.035 (+2.55%)
Streaming Delayed Price
Updated: 11:45 AM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atossa Therapeutics Inc
< Previous
1
2
3
4
5
Next >
The 3 Best Biotech Stocks Under $1 to Buy for January
January 26, 2023
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Monday
December 05, 2022
During Monday's session, 49 companies made new 52-week lows.
Via
Benzinga
Recap: Atossa Therapeutics Q2 Earnings
August 08, 2022
Atossa Therapeutics (NASDAQ:ATOS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:30 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Is NuZee Down By Over 21%: Here Are 38 Stocks Moving Premarket
August 08, 2022
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares rose 46% to $6.98 in pre-market trading after jumping around 46% on Friday. The company recently said it expects unaudited...
Via
Benzinga
20 Stocks Moving in Wednesday's Pre-Market Session
June 08, 2022
Gainers Cyren Ltd. (NASDAQ: CYRN) rose 31.1% to $2.32 in pre-market trading after the company entered into an agreement with Content Services Group to sell all equity interests in its legacy secure...
Via
Benzinga
61 Biggest Movers From Yesterday
April 28, 2022
Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with...
Via
Benzinga
Analyzing Atossa Therapeutics's Unusual Options Activity
August 04, 2021
Atossa Therapeutics (NASDAQ:ATOS) shares experienced unusu...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 07, 2022
Gainers ContraFect (NASDAQ:CFRX) stock mo...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 06, 2022
Gainers ContraFect (NASDAQ:CFRX) stock in...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 20, 2021
Gainers Tenet Healthcare (NYSE:THC) stock r...
Via
Benzinga
ATOS Stock Holders Should Mark Their Calendars for Oct. 7
September 10, 2021
Today, investors in Atossa Pharmaceuticals and ATOS stock appear to be cheering a delayed shareholder vote on a stock issuance proposal.
Via
InvestorPlace
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Via
Benzinga
Exposures
Product Safety
Atossa To Conduct Endoxifen Mid-Stage Study In Sweden
September 02, 2021
Atossa Therapeutics Inc (NASDAQ: ATOS) has received approval from the Swedish Ethics Review Authority to begin a Phase 2 clinical study of oral Endoxifen to reduce...
Via
Benzinga
Atossa Therapeutics Stock Lost Its Covid Mojo, and Its Pipeline Fails To Impress
August 31, 2021
Atossa’s Covid treatment is too little too late and I am concerned about the market size for Endoxiden. Avoid ATOS stock here.
Via
InvestorPlace
Atossa Therapeutics Has a Steep Climb Ahead of It
August 31, 2021
Atossa Therapeutics is popular with the Reddit crowd. However, ATOS stock doesn’t make the top 25 on the platform. Should you buy it anyway?
Via
InvestorPlace
Exposures
COVID-19
As its Meme Status Has Come and Gone, Skip Out on Atossa Therapeutics Stock
August 30, 2021
No matter talked about by the Reddit set, despite its heavy short-interest, ATOS stock will likely fall lower rather than get squeezed
Via
InvestorPlace
Exposures
COVID-19
Atossa Therapeutics May Look Tempting, but There’s No Reason to Get in Now
August 30, 2021
ATOS stock has some exciting points, but its story sends a message investors have heard, namely the price of progress is dilution.
Via
InvestorPlace
With Zero Revenue, I Can’t Get Excited About Atossa
August 17, 2021
ATOS stock surged briefly in 2021 based on several catalysts, but none of them right now is supportive of its current price and valuation.
Via
InvestorPlace
Exposures
COVID-19
88 Biggest Movers From Yesterday
August 05, 2021
Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in...
Via
Benzinga
The Bear Case for Atossa Therapeutics Makes More Sense at This Time
August 04, 2021
Investors have become wary of the risks surrounding Atossa's pipeline. That caution will continue pulling down ATOS stock.
Via
InvestorPlace
Most Active Equity Options For Midday - Wednesday, Aug. 4
August 04, 2021
Top Tickers: AMD, AAPL, TSLA, AMC, PFE, NVDA, GM, FB, BABA, MRNA, F, SOFI, HOOD, MU, UBER, BA, ATOS, AMZN, ATVI, NIO.
Via
Talk Markets
Investors Should Avoid High-Risk Atossa Therapeutics
August 02, 2021
Given the early stages of Atossa's clinical trials, ATOS stock is too risky to get involved with at this point.
Via
InvestorPlace
The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs
July 31, 2021
A look at lessons learned from active trading of IPOs, ETFs, Russian Dolls, and a discussion on what might be the secret to trading-which ironically, is the polar opposite to trading.
Via
Talk Markets
63 Biggest Movers From Friday
August 02, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the...
Via
Benzinga
Exposures
Product Safety
ATOS Stock: The Big News That Has Atossa Therapeutics Plunging 20% Today
July 30, 2021
ATOS stock is on its way down today. As the biotech company announces a special shareholder meeting, holders worry about stock dilution.
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Friday's Intraday Session
July 30, 2021
Gainers Erytech Pharma (NASDAQ:ERYP) sha...
Via
Benzinga
41 Stocks Moving In Friday's Mid-Day Session
July 30, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares jumped 90.6% to $7.84 after the company said the FDA has granted its eryaspase fast track designation for the treatment of acute...
Via
Benzinga
Exposures
Product Safety
20 Stocks Moving in Friday's Pre-Market Session
July 30, 2021
Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares rose 50.9% to $6.20 in pre-market trading after the company announced its eryaspase was granted U.S. FDA Fast Track designation...
Via
Benzinga
Exposures
Product Safety
Understanding Atossa Therapeutics's Unusual Options Activity
July 29, 2021
Atossa Therapeutics (NASDAQ:ATOS) shares experienced unusual options activity on Thursday. The stock price moved up to $4.08 following the option alert. Sentiment: BEARISH...
Via
Benzinga
Wait for Atossa Therapeutics Stock to Slide Further Before Buying
July 28, 2021
The potential with its breast cancer and Covid-19 treatment candidates notwithstanding, don't fight the trend with ATOS stock.
Via
InvestorPlace
Exposures
COVID-19
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.